LOW-FAT DIET VERSUS LOW-CARBOHYDRATE DIET IN THE TREATMENT OF TYPE IV HYPERLIPOPROTEINAEMIA.SOMMARIVA D; SCOTTI L; FASOLI A et al.1978; ATHEROSCLEROSIS; NETHERL.; DA. 1978; VOL. 29; NO 1; PP. 43-51; BIBL. 1 P. 1/2Article

INACTIVATION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE IN CULTURED HUMAN BLOOD MONONUCLEAR CELLS BY PROCETOPENIC ACIDMASSAROLI C; SOMMARIVA D; BORTOLINI U et al.1982; PHARMACOL. RES. COMMUN.; ISSN 0031-6989; GBR; DA. 1982; VOL. 14; NO 1; PP. 51-60; BIBL. 23 REF.Article

EFFECTS OF ACETYLSALICYCLIC ACID ON PLASMA LIPIDS AND ON POST-HEPARIN LIPASE ACTIVITIESSOMMARIVA D; BONFIGLIOLI D; ZANABONI L et al.1981; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1981; VOL. 19; NO 3; PP. 112-116; BIBL. 2 P.Article

EVIDENCE OF AN EFFECT OF INHALED DISODIUM CROMOGLYCATE ON LIPID METABOLISM IN MAN: ENHANCED LIPOLYSIS AND DECREASED PLASMA POSTHEPARIN LIPASE ACTIVITIESSOMMARIVA D; ZANABONI L; BONFIGLIOLI D et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 3; PP. 122-127; BIBL. 33 REF.Article

INCREASE IN LIPOLYSIS AND DECREASE IN PLASMA-HEPARIN LIPOPROTEIN LIPASE ACTIVITY AND ALPHA₁ LIPOPROTEIN LEVEL AFTER AMINOPHYLLINE IN MANZANABONI L; BONFIGLIOLI D; SOMMARIVA D et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 19; NO 5; PP. 349-351; BIBL. 16 REF.Article

AN EVALUATION OF QUANTITATIVE AGAROSE-GEL ELECTROPHORESIS OF SERUM LIPOPROTEINS.FASOLI A; SOMMARIVA D; SCOTTI L et al.1978; CLIN. CHIM. ACTA; NLD; DA. 1978; VOL. 87; NO 3; PP. 341-345; BIBL. 16 REF.Article

The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride levelBRANCHI, A; ROVELLINI, A; FIORENZA, A. M et al.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 9, pp 384-389, issn 0946-1965Article

Lipids and lipoproteins in obese adolescents during a hypocaloric dietSTERPA, A; PAPPINI, A; PICCIOTTI, M et al.International journal of obesity. 1984, Vol 8, Num 5, pp 467-468, issn 0307-0565Article

Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjectsFIORENZA, A. M; BRANCHI, A; SOMMARIVA, D et al.International journal of clinical & laboratory research. 2000, Vol 30, Num 3, pp 141-145, issn 0940-5437Article

INFLUENCE OF TWO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON LIPOLYSIS AND ON PLASMA POST-HEPARIN LIPOPROTEIN LIPASE ACTIVITY IN NORMAL MANBONFIGLIOLI D; SOMMARIVA D; ZANABONI L et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 4; PP. 263-267; BIBL. 40 REF.Article

Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patientsBRANCHI, A; TORRI, A; ROVELLINI, A et al.Diabetes care. 1998, Vol 21, Num 9, pp 1397-1402, issn 0149-5992Article

Effects of benfluorex on sterol biosynthesis in incubated human blood mononuclear cellsSOMMARIVA, D; BLASI, F; COSENTINI, R et al.Drugs under experimental and clinical research. 1986, Vol 12, Num 11, pp 923-927, issn 0378-6501Article

Lowering effects of four different statins on serum triglyceride levelBRANCHI, A; FIORENZA, A. M; ROVELLINI, A et al.European journal of clinical pharmacology. 1999, Vol 55, Num 7, pp 499-502, issn 0031-6970Article

Bezafibrate inhibits HMG-COA reductase activity in incubated blood mononuclear cells from normal subjects and patients with heterozygous familial hypercholesterolaemiaBLASI, F; SOMMARIVA, D; COSENTINI, R et al.Pharmacological research. 1989, Vol 21, Num 3, pp 247-254, issn 1043-6618Article

Changes in serum lipoprotein pattern following bezafibrate. Differential effects in type IIa and in type IIb hyperlipoproteinemicSOMMARIVA, D; TIRRITO, M; BONFIGLIOLI, D et al.Pharmacological research communications. 1985, Vol 17, Num 12, pp 1181-1191, issn 0031-6989Article

Association of alcohol consumption with HDL subpopulations defined by apolipoprotein A-I and apolipoprotein A-II contentBRANCHI, A; ROVELLINI, A; TOMELLA, C et al.European journal of clinical nutrition. 1997, Vol 51, Num 6, pp 362-365, issn 0954-3007Article

Differential effects of simvastatin and bezafibrate on apolipoprotein-defined high-density lipoprotein subfractions in patients with hypercholesterolemiaBRANCHI, A; ROVELLINI, A; SOMMARIVA, D et al.Current therapeutic research. 1996, Vol 57, Num 1, pp 26-32, issn 0011-393XArticle

Effect of bezafibrate on HDL with apo A-I and apo A-II and on HDL with apo A-I without apo A-II in hyperlipidaemic patientsBRANCHI, A; ROVELLINI, A; SOMMARIVA, D et al.International journal of clinical pharmacology research. 1995, Vol 15, Num 4, pp 153-158, issn 0251-1649Article

Probucol and cholestyramine combination in the treatment of severe hypercholesterolemiaSOMMARIVA, D; BONFIGLIOLI, D; TIRRITO, M et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1986, Vol 24, Num 9, pp 505-510, issn 0174-4879Article

Long-term effects of low-dose simvastatin in hypercholesterolemic type 2 diabetic patientsTORRI, A; SOMMARIVA, D; MARAFFI, F et al.Current therapeutic research. 1992, Vol 51, Num 1, pp 28-36, issn 0011-393XArticle

Inhibition of cholesterol biosynthesis in freshly isolated blood mononuclear cells from normolipidemic subjects and hypercholesterolemic patients treated with bezafibrateCOSENTINI, R; BLASI, F; TRINCHERA, M et al.Atherosclerosis. 1989, Vol 79, Num 2-3, pp 253-255, issn 0021-9150Article

Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozilSOMMARIVA, D; BRANCHI, A; PINI, C et al.International journal of clinical pharmacology research. 1988, Vol 8, Num 5, pp 383-392, issn 0251-1649Article

Changes in lipoprotein cholesterol and triglycerides induced by acipimox in type IV and type II hyperlipoproteinemic patientsSOMMARIVA, D; POGLIAGHI, I; BONFIGLIOLI, D et al.Current therapeutic research. 1985, Vol 37, Num 2, pp 363-368, issn 0011-393XArticle

Effects of procetofen on seum serum lipids and lipoproteins and on plasma post-heparin lipase activities in type II and in type IV hyperlipoproteinemic patientsSOMMARIVA, D; BONFIGIOLI, D; POGLIAGHI, I et al.Current therapeutic research. 1983, Vol 34, Num 5, pp 907-915, issn 0011-393XArticle

Effects of slow release bezafibrate on the lipid pattern and on blood glucose of type 2 diabetic patients with hyperlipidaemiaROVELLINI, A; SOMMARIVA, D; BRANCHI, A et al.Pharmacological research. 1992, Vol 25, Num 3, pp 237-245, issn 1043-6618Article